MT1B | Metallothionein 1B | | | | | | Group enriched |
MTTP | Microsomal triglyceride transfer protein | Disease related genes FDA approved drug targets Predicted secreted proteins
| | | | | Group enriched |
MUC13 | Mucin 13, cell surface associated | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
MUC17 | Mucin 17, cell surface associated | Cancer-related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
MUC2 | Mucin 2, oligomeric mucus/gel-forming | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
MUC3A | Mucin 3A, cell surface associated | Predicted membrane proteins
| | | | | Group enriched |
MUC6 | Mucin 6, oligomeric mucus/gel-forming | Predicted secreted proteins
| | | | | Group enriched |
MYO1A | Myosin IA | Disease related genes Plasma proteins
| | | | | Group enriched |
MYRFL | Myelin regulatory factor-like | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) | Cancer-related genes Enzymes
| | | | | Group enriched |
NEUROD1 | Neuronal differentiation 1 | Disease related genes Transcription factors
| | | | | Group enriched |
NKX6-3 | NK6 homeobox 3 | Transcription factors
| | | | | Group enriched |
NLRP6 | NLR family, pyrin domain containing 6 | Plasma proteins
| | | | | Group enriched |
NOS2 | Nitric oxide synthase 2, inducible | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
NPC1L1 | NPC1-like 1 | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
NR1I2 | Nuclear receptor subfamily 1, group I, member 2 | FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Group enriched |
OTC | Ornithine carbamoyltransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
PCK2 | Phosphoenolpyruvate carboxykinase 2 (mitochondrial) | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
PIGR | Polymeric immunoglobulin receptor | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
PLA2G12B | Phospholipase A2, group XIIB | Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
PLCB3 | Phospholipase C, beta 3 (phosphatidylinositol-specific) | Enzymes
| | | | | Group enriched |
PPP1R14D | Protein phosphatase 1, regulatory (inhibitor) subunit 14D | | | | | | Group enriched |
PRAP1 | Proline-rich acidic protein 1 | Predicted secreted proteins
| | | | | Group enriched |
RBP2 | Retinol binding protein 2, cellular | Transporters
| | | | | Group enriched |
REG1A | Regenerating islet-derived 1 alpha | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
REG3A | Regenerating islet-derived 3 alpha | Plasma proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
REG4 | Regenerating islet-derived family, member 4 | Predicted secreted proteins
| | | | | Group enriched |
REP15 | RAB15 effector protein | | | | | | Group enriched |
RP11-595B24.2 | Uncharacterized protein | | | | | | Group enriched |
RP11-77K12.7 | | | | | | | Group enriched |
SHD | Src homology 2 domain containing transforming protein D | | | | | | Group enriched |
SI | Sucrase-isomaltase (alpha-glucosidase) | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
SLC10A2 | Solute carrier family 10 (sodium/bile acid cotransporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC13A2 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC15A1 | Solute carrier family 15 (oligopeptide transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC17A4 | Solute carrier family 17, member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC23A3 | Solute carrier family 23, member 3 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
SLC26A3 | Solute carrier family 26 (anion exchanger), member 3 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC28A1 | Solute carrier family 28 (concentrative nucleoside transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC2A7 | Solute carrier family 2 (facilitated glucose transporter), member 7 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC35G1 | Solute carrier family 35, member G1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC39A5 | Solute carrier family 39 (zinc transporter), member 5 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
SLC52A1 | Solute carrier family 52 (riboflavin transporter), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC5A1 | Solute carrier family 5 (sodium/glucose cotransporter), member 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC5A11 | Solute carrier family 5 (sodium/inositol cotransporter), member 11 | Predicted membrane proteins
| | | | | Group enriched |
SLC5A4 | Solute carrier family 5 (glucose activated ion channel), member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC5A9 | Solute carrier family 5 (sodium/sugar cotransporter), member 9 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC6A19 | Solute carrier family 6 (neutral amino acid transporter), member 19 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC6A4 | Solute carrier family 6 (neurotransmitter transporter), member 4 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC7A9 | Solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |